BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16393779)

  • 21. The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains.
    Kay BK; Williamson MP; Sudol M
    FASEB J; 2000 Feb; 14(2):231-41. PubMed ID: 10657980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ligand-regulated association of ErbB-4 to the transcriptional co-activator YAP65 controls transcription at the nuclear level.
    Omerovic J; Puggioni EM; Napoletano S; Visco V; Fraioli R; Frati L; Gulino A; Alimandi M
    Exp Cell Res; 2004 Apr; 294(2):469-79. PubMed ID: 15023535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. WW domains provide a platform for the assembly of multiprotein networks.
    Ingham RJ; Colwill K; Howard C; Dettwiler S; Lim CS; Yu J; Hersi K; Raaijmakers J; Gish G; Mbamalu G; Taylor L; Yeung B; Vassilovski G; Amin M; Chen F; Matskova L; Winberg G; Ernberg I; Linding R; O'donnell P; Starostine A; Keller W; Metalnikov P; Stark C; Pawson T
    Mol Cell Biol; 2005 Aug; 25(16):7092-106. PubMed ID: 16055720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural insights into the role of the WW2 domain on tandem WW-PPxY motif interactions of oxidoreductase WWOX.
    Rotem-Bamberger S; Fahoum J; Keinan-Adamsky K; Tsaban T; Avraham O; Shalev DE; Chill JH; Schueler-Furman O
    J Biol Chem; 2022 Aug; 298(8):102145. PubMed ID: 35716775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solution structures of the YAP65 WW domain and the variant L30 K in complex with the peptides GTPPPPYTVG, N-(n-octyl)-GPPPY and PLPPY and the application of peptide libraries reveal a minimal binding epitope.
    Pires JR; Taha-Nejad F; Toepert F; Ast T; Hoffmüller U; Schneider-Mergener J; Kühne R; Macias MJ; Oschkinat H
    J Mol Biol; 2001 Dec; 314(5):1147-56. PubMed ID: 11743730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear localization of active HGF receptor Met in aggressive MDA-MB231 breast carcinoma cells.
    Matteucci E; Bendinelli P; Desiderio MA
    Carcinogenesis; 2009 Jun; 30(6):937-45. PubMed ID: 19357348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using molecular repertoires to identify high-affinity peptide ligands of the WW domain of human and mouse YAP.
    Linn H; Ermekova KS; Rentschler S; Sparks AB; Kay BK; Sudol M
    Biol Chem; 1997 Jun; 378(6):531-7. PubMed ID: 9224934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity.
    Chang NS; Pratt N; Heath J; Schultz L; Sleve D; Carey GB; Zevotek N
    J Biol Chem; 2001 Feb; 276(5):3361-70. PubMed ID: 11058590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure of FBP11 WW1-PL ligand complex reveals the mechanism of proline-rich ligand recognition by group II/III WW domains.
    Kato Y; Miyakawa T; Kurita J; Tanokura M
    J Biol Chem; 2006 Dec; 281(52):40321-9. PubMed ID: 17065151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural insights into the functional versatility of WW domain-containing oxidoreductase tumor suppressor.
    Farooq A
    Exp Biol Med (Maywood); 2015 Mar; 240(3):361-74. PubMed ID: 25662954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. WW domain-containing proteins: retrospectives and the future.
    Salah Z; Alian A; Aqeilan RI
    Front Biosci (Landmark Ed); 2012 Jan; 17(1):331-48. PubMed ID: 22201747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules.
    Chen HI; Sudol M
    Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7819-23. PubMed ID: 7644498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multivalent binding of formin-binding protein 21 (FBP21)-tandem-WW domains fosters protein recognition in the pre-spliceosome.
    Klippel S; Wieczorek M; Schümann M; Krause E; Marg B; Seidel T; Meyer T; Knapp EW; Freund C
    J Biol Chem; 2011 Nov; 286(44):38478-38487. PubMed ID: 21917930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploiting the basis of proline recognition by SH3 and WW domains: design of N-substituted inhibitors.
    Nguyen JT; Turck CW; Cohen FE; Zuckermann RN; Lim WA
    Science; 1998 Dec; 282(5396):2088-92. PubMed ID: 9851931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functions of WW domains in the nucleus.
    Sudol M; Sliwa K; Russo T
    FEBS Lett; 2001 Feb; 490(3):190-5. PubMed ID: 11223034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of a novel protein-binding module--the WW domain.
    Sudol M; Chen HI; Bougeret C; Einbond A; Bork P
    FEBS Lett; 1995 Aug; 369(1):67-71. PubMed ID: 7641887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WW and SH3 domains, two different scaffolds to recognize proline-rich ligands.
    Macias MJ; Wiesner S; Sudol M
    FEBS Lett; 2002 Feb; 513(1):30-7. PubMed ID: 11911877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrating folding kinetics and protein function: biphasic kinetics and dual binding specificity in a WW domain.
    Karanicolas J; Brooks CL
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3432-7. PubMed ID: 14981252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cooperative and selective roles of the WW domains of the yeast Nedd4-like ubiquitin ligase Rsp5 in the recognition of the arrestin-like adaptors Bul1 and Bul2.
    Watanabe D; Murai H; Tanahashi R; Nakamura K; Sasaki T; Takagi H
    Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):76-81. PubMed ID: 25998383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of WW domain-containing oxidoreductase leads to tamoxifen-resistance by the inactivation of Hippo signaling.
    Li J; Feng X; Li C; Liu J; Li P; Wang R; Chen H; Liu P
    Exp Biol Med (Maywood); 2019 Sep; 244(12):972-982. PubMed ID: 31155927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.